EANS-Voting Rights: Marinomed Biotech AG / Publication of aparticipation notification according to art. 135 para. 2 StockExchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018 Wien, 4.2.2019 Overview
1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Other
3. Person subject to notification obligation
Name: Republik Österreich
City: Österreich
Country: Österreich
4. Name of shareholder(s): aws Mittelstandsfonds Beteiligungs GmbH & Co KG 5. Date on which the threshold was crossed or reached: 1.2.2019
6. Total positions

______________________________________________________________________________
| | | % of voting | | |
| | % of voting |rights through |Total of both |Total number of|
| |rights attached|financial/other| in % (7.A + | voting rights |
| |to shares (7.A)| instruments | 7.B) | of issuer |
|_______________|_______________|(7.B.1_+_7.B.2)|______________|_______________|
| Resulting | | | | |
| situation on | | | | |
| the date on | 8,47 % | 0,00 % | 8,47 % | 1 260 000 |
|which threshold| | | | |
| was crossed / | | | | |
|____reached____|_______________|_______________|______________|_______________|
| Position of | | | | |
| previous | | | | |
| notification | | | | |
|(if_applicable)|_______________|_______________|______________|_______________|

Details
7. Notified details of the resulting situation:

______________________________________________________________________________
|A:_Voting_rights_attached_to_shares___________________________________________|
| |____Number_of_voting_rights____|_______%_of_voting_rights_______|
| | Direct | Indirect | Direct | Indirect |
| ISIN Code |(Sec 130 BörseG|(Sec 133 BörseG|(Sec 130 BörseG|(Sec 133 BörseG |
|_____________|_____2018)_____|_____2018)_____|_____2018)_____|_____2018)______|
|ATMARINOMED6_|_______________|________106_666|_______________|__________8,47_%|
|_SUBTOTAL_A__|____________106_666____________|_____________8,47_%_____________|

______________________________________________________________________________
|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG |
|2018__________________________________________________________________________|
| | | |Number of voting | |
| | | | rights that may | |
| Type of | | | be | % of voting |
| instrument |Expiration Date|Exercise Period|acquired if the | rights |
| | | | instrument is | |
|_____________|_______________|_______________|____exercised____|______________|
|_____________|_______________|_SUBTOTAL_B.1__|_________________|______________|

_____________________________________________________________________________
|B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG |
|2018_________________________________________________________________________|
| Type of | Expiration | Exercise | Physical / | Number of |% of voting |
|instrument | Date | Period | Cash |voting rights| rights |
|___________|____________|___________|_Settlement__|_____________|____________|
|___________|____________|___________|SUBTOTAL_B.2_|_____________|____________|

8. Information in relation to the person subject to the notification obligation:
Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

______________________________________________________________________________
| | | | |Financial/ | |
| | | Directly |Shares held| other | |
| No. | Name |controlled | directly |instruments| Total of |
| | | by No. | (%) | held | both (%) |
| | | | | directly | |
|__________|__________________|___________|___________|____(%)____|____________|
| 1 |Republik | | | | |
|__________|Österreich________|___________|___________|___________|____________|
| |Austria | | | | |
| 2 |Wirtschaftsservice| 1 | | | |
|__________|GmbH______________|___________|___________|___________|____________|
| |aws | | | | |
| 3 |Fondsmanagement | 2 | | | |
|__________|GmbH______________|___________|___________|___________|____________|
| |aws | | | | |
| 4 |Mittelstandsfonds | 3 | 8,47 %| | 8,47 %|
| |Beteiligungs GmbH | | | | |
|__________|&_Co_KG___________|___________|___________|___________|____________|

9. In case of proxy voting
Date of general meeting: –
Voting rights after general meeting: – is equivalent to – voting rights. 10. Sonstige Kommentare:
Die Meldung erfolgt aufgrund der erstmaligen Zulassung gem § 130 Abs 7 BörseG 2018.
Korrektur der zuvor gesendeten Meldung, da laut Emittent Kapitalerhöhung eingetragen vor Zustellung des Zulassungsbescheids und somit Anzahl Stimmrechte nach Kapitalerhöhung zu melden sind.
Wien am 4.2.2019

end of announcement euro adhoc

issuer: Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
phone: 0043250774460
FAX: 0043250774493
mail: office@marinomed.com
WWW: www.marinomed.com
ISIN: ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language: English

Digital press kit: http://www.ots.at/pressemappe/31479/aom

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS. www.ots.at
© Copyright APA-OTS Originaltext-Service GmbH und der jeweilige Aussender